Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

Similar articles for PubMed (Select 24869763)

1.

The risk of recurrent IgA nephropathy in a steroid-free protocol and other modifying immunosuppression.

Von Visger JR, Gunay Y, Andreoni KA, Bhatt UY, Nori US, Pesavento TE, Elkhammas EA, Winters HA, Nadasdy T, Singh N.

Clin Transplant. 2014 Aug;28(8):845-54. doi: 10.1111/ctr.12389. Epub 2014 Jun 24.

PMID:
24869763
2.

Steroids and recurrent IgA nephropathy after kidney transplantation.

Clayton P, McDonald S, Chadban S.

Am J Transplant. 2011 Aug;11(8):1645-9. doi: 10.1111/j.1600-6143.2011.03667.x.

3.

Evaluation of tonsillectomy before kidney transplantation in patients with IgA nephropathy.

Sato Y, Ishida H, Shimizu T, Tanabe K.

Transpl Immunol. 2014 Jan;30(1):12-7. doi: 10.1016/j.trim.2013.11.001. Epub 2013 Nov 16.

PMID:
24246415
4.

IgA nephropathy recurs early in the graft when assessed by protocol biopsy.

Ortiz F, Gelpi R, Koskinen P, Manonelles A, Räisänen-Sokolowski A, Carrera M, Honkanen E, Grinyó JM, Cruzado JM.

Nephrol Dial Transplant. 2012 Jun;27(6):2553-8. doi: 10.1093/ndt/gfr664. Epub 2011 Dec 13.

5.

Latent IgA deposition from donor kidney is the major risk factor for recurrent IgA nephropathy in renal transplantation.

Moriyama T, Nitta K, Suzuki K, Honda K, Horita S, Uchida K, Yumura W, Tanabe K, Toma H, Nihei H, Yamaguchi Y.

Clin Transplant. 2005;19 Suppl 14:41-8.

PMID:
15955168
6.

Recurrent IgA nephropathy after renal transplantation despite immunosuppressive regimens with mycophenolate mofetil.

Chandrakantan A, Ratanapanichkich P, Said M, Barker CV, Julian BA.

Nephrol Dial Transplant. 2005 Jun;20(6):1214-21. Epub 2005 Mar 29.

7.

Risk factors for graft loss in patients with recurrent IGA nephropathy after renal transplantation.

Namba Y, Oka K, Moriyama T, Ichimaru N, Kyo M, Kokado Y, Ito T, Imai E, Aozasa K, Okuyama A, Takahara S.

Transplant Proc. 2004 Jun;36(5):1314-6.

PMID:
15251321
8.

The long-term outcome of renal transplantation of IgA nephropathy and the impact of recurrence on graft survival.

Moroni G, Longhi S, Quaglini S, Gallelli B, Banfi G, Montagnino G, Messa P.

Nephrol Dial Transplant. 2013 May;28(5):1305-14. doi: 10.1093/ndt/gfs472. Epub 2012 Dec 9.

9.

Impact of recurrent disease and chronic allograft nephropathy on the long-term allograft outcome in patients with IgA nephropathy.

Han SS, Huh W, Park SK, Ahn C, Han JS, Kim S, Kim YS.

Transpl Int. 2010 Feb;23(2):169-75. doi: 10.1111/j.1432-2277.2009.00966.x. Epub 2009 Sep 16. Erratum in: Transpl Int. 2010 Aug;23(8):860.

PMID:
19761553
10.

Favorable outcome of renal transplantation in patients with IgA nephropathy.

Andresdottir MB, Hoitsma AJ, Assmann KJ, Wetzels JF.

Clin Nephrol. 2001 Oct;56(4):279-88.

PMID:
11680657
11.

Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.

Anil Kumar MS, Irfan Saeed M, Ranganna K, Malat G, Sustento-Reodica N, Kumar AM, Meyers WC.

Transpl Immunol. 2008 Nov;20(1-2):32-42. doi: 10.1016/j.trim.2008.08.005. Epub 2008 Sep 4.

PMID:
18773960
12.

Excellent clinical outcomes in primary kidney transplant recipients treated with steroid-free maintenance immunosuppression.

Rajab A, Pelletier RP, Henry ML, Ferguson RM.

Clin Transplant. 2006 Sep-Oct;20(5):537-46.

PMID:
16968478
13.

Early steroid withdrawal therapy in renal transplant recipients: a steroid-free sirolimus and CellCept-based calcineurin inhibitor-minimization protocol.

Jaber JJ, Feustel PJ, Elbahloul O, Conti AD, Gallichio MH, Conti DJ.

Clin Transplant. 2007 Jan-Feb;21(1):101-9.

PMID:
17302598
14.

IgA serology in recurrent and non-recurrent IgA nephropathy after renal transplantation.

Coppo R, Amore A, Cirina P, Messina M, Basolo B, Segoloni G, Berthoux F, Boulharouz R, Egido J, Alcazar R, et al.

Nephrol Dial Transplant. 1995 Dec;10(12):2310-5.

PMID:
8808231
15.

Tonsillectomy and steroid pulse therapy for recurrent IgA nephropathy in renal allograft.

Tsuchiya T, Ito S, Yamaguchi Y, Moriyama Y, Ehara H, Deguchi T.

Clin Nephrol. 2010 Jan;73(1):68-71.

PMID:
20040355
16.

Single-center long-term results of renal transplantation for IgA nephropathy.

Bumgardner GL, Amend WC, Ascher NL, Vincenti FG.

Transplantation. 1998 Apr 27;65(8):1053-60.

PMID:
9583865
17.

Renal transplantation in patients with primary immunoglobulin A nephropathy.

Choy BY, Chan TM, Lo SK, Lo WK, Lai KN.

Nephrol Dial Transplant. 2003 Nov;18(11):2399-404.

18.

Steroid-free immunosuppression in pediatric renal transplantation: rationale for and [corrected] outcomes following conversion to steroid based therapy.

Sutherland S, Li L, Concepcion W, Salvatierra O, Sarwal MM.

Transplantation. 2009 Jun 15;87(11):1744-8. doi: 10.1097/TP.0b013e3181a5df60. Erratum in: Transplantation. 2009 Sep 27;88(6):852.

19.

Influence of induction modality on the outcome of deceased donor kidney transplant recipients discharged on steroid-free maintenance immunosuppression.

Sureshkumar KK, Thai NL, Hussain SM, Ko TY, Marcus RJ.

Transplantation. 2012 Apr 27;93(8):799-805. doi: 10.1097/TP.0b013e3182472898.

PMID:
22290269
20.

Long term outcome of renal allografts in patients with immunoglobulin A nephropathy.

Ng YS, Vathsala A, Chew ST, Chiang GS, Woo KT.

Med J Malaysia. 2007 Jun;62(2):109-13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk